P53 gene mutations have been implicated in several human cancers, such as liver cancer, breast cancer, bladder cancer, gastric, colon, prostate, soft tissue sarcoma, ovarian cancer, lymphocytic tumor, esophageal cancer, lung cancer, and osteosarcoma. Here, TP53 is linked to soft tissue sarcoma.